Relevance of CYP17A1 Blockade in Clones of Castration-resistant Prostate Cancer

被引:0
|
作者
Kumagai, J. [1 ]
Erkens-Schulze, S. [2 ]
Dits, N. F. J. [2 ]
de Wit, R. [3 ]
van Weerden, W. M. [1 ]
机构
[1] Univ Tokyo, Tokyo, Japan
[2] Erasmus MC, Rotterdam, Netherlands
[3] Erasmus MC, Med Oncol, Rotterdam, Netherlands
关键词
D O I
10.1016/S0959-8049(12)72094-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
296
引用
收藏
页码:90 / 91
页数:2
相关论文
共 50 条
  • [31] Azacitidine for castration-resistant prostate cancer progressing on combined androgen blockade
    Sonpavde, G.
    Aparicio, A. M.
    Delaune, R.
    Garbo, L. E.
    Rousey, S. R.
    Weinstein, R. E.
    Williams, A.
    Zhan, F.
    Boehm, K. A.
    Asmar, L.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Predicting castration-resistant prostate cancer after combined androgen blockade
    He, Miao
    Liu, Haina
    Cao, Jingyi
    Wang, Qian
    Xu, Haiting
    Wang, Yufeng
    ONCOTARGET, 2017, 8 (62) : 105458 - 105462
  • [33] ANALYSIS OF UP-REGULATED CYP17A1 EXPRESSION UNDER ANTI-ANDROGEN STRATEGIES IN CASTRATION RESISTANT PROSTATE CANCER
    Heinrich, Elmar
    Tojan, Lutz
    Bremmer, Felix
    Strauss, Arne
    Thelen, Paul
    JOURNAL OF UROLOGY, 2013, 189 (04): : E131 - E131
  • [34] Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
    S Salvi
    V Casadio
    V Conteduca
    S L Burgio
    C Menna
    E Bianchi
    L Rossi
    E Carretta
    C Masini
    D Amadori
    D Calistri
    G Attard
    U De Giorgi
    British Journal of Cancer, 2015, 112 : 1717 - 1724
  • [35] Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
    Salvi, S.
    Casadio, V.
    Conteduca, V.
    Burgio, S. L.
    Menna, C.
    Bianchi, E.
    Rossi, L.
    Carretta, E.
    Masini, C.
    Amadori, D.
    Calistri, D.
    Attard, G.
    De Giorgi, U.
    BRITISH JOURNAL OF CANCER, 2015, 112 (10) : 1717 - 1724
  • [36] Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones
    Leung, Jacky K.
    Tam, Teresa
    Wang, Jun
    Sadar, Marianne D.
    HUMAN CELL, 2021, 34 (01) : 211 - 218
  • [37] Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones
    Jacky K. Leung
    Teresa Tam
    Jun Wang
    Marianne D. Sadar
    Human Cell, 2021, 34 : 211 - 218
  • [38] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [39] Immunotherapy for Castration-Resistant Prostate Cancer
    Sonpavde, Guru
    Kantoff, Philip W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 465 - +
  • [40] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438